Mitochondrial ferritin in neurodegenerative diseases

Neuroscience Research

Volumn 77, Issue 1-2, 2013, Pages 1-7

  Yang, Hongkuan ^a,b   Yang, Mingchun ^a,b   Guan, Hongpeng ^a,b   Liu, Ziyi ^a,b   Zhao, Shiguang ^b   Takeuchi, Shigeko ^a   Yanagisawa, Daijiro ^a   Tooyama, Ikuo ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease, Restless legs syndrome; Iron; Oxidative stress; Substantia nigra; Transition metal

Indexed keywords

AMYLOID BETA PROTEIN; FERRITIN; FERROPORTIN; FRATAXIN; HYDROGEN PEROXIDE; IRON BINDING PROTEIN; LACTOFERRIN; LACTOFERRIN RECEPTOR; MITOCHONDRIAL FERRITIN; MITOFERRIN; PROTEIN BCL 2; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN CORTEX; BRAIN METABOLISM; CANCER CELL CULTURE; CELL DEATH; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; FRIEDREICH ATAXIA; GENE MUTATION; HUMAN; IRON METABOLISM; IRON OVERLOAD; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RESTLESS LEGS SYNDROME; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SUBSTANTIA NIGRA;

ALZHEIMER'S DISEASE, RESTLESS LEGS SYNDROME; IRON; OXIDATIVE STRESS; SUBSTANTIA NIGRA; TRANSITION METAL;

BRAIN; FERRITINS; HUMANS; IRON; MITOCHONDRIAL PROTEINS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 84886426499     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2013.07.005     Document Type: Review

References (89)

1. Allen R.P., Barker P.B., Wehrl F., Song H.K., Earley C.J. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001, 56:263-265.
2. Altamura S., Muckenthaler M.U. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. Journal of Alzheimer's Disease 2009, 16:879-895.
3. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:7915-7922.
4. An L., Sato H., Konishi Y., Walker D.G., Beach T.G., Rogers J., Tooyama I. Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease. Neuroscience Letters 2009, 452:277-280.
5. Bartzokis G., Sultzer D., Cummings J., Holt L.E., Hance D.B., Henderson V.W., Mintz J. In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Archives of General Psychiatry 2000, 57:47-53.
6. Batista-Nascimento L., Pimentel C., Menezes R.A., Rodrigues-Pousada C. Iron and neurodegeneration: from cellular homeostasis to disease. Oxidative Medicine and Cellular Longevity 2012, 2012:128647.
7. Burdo J.R., Menzies S.L., Simpson I.A., Garrick L.M., Garrick M.D., Dolan K.G., Haile D.J., Beard J.L., Connor J.R. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. Journal of Neuroscience Research 2001, 66:1198-1207.
8. Campanella A., Isaya G., O'Neill H.A., Santambrogio P., Cozzi A., Arosio P., Levi S. The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast. Human Molecular Genetics 2004, 13:2279-2288.
9. Campanella A., Rovelli E., Santambrogio P., Cozzi A., Taroni F., Levi S. Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia. Human Molecular Genetics 2009, 18:1-11.
10. Casadesus G., Smith M.A., Zhu X., Aliev G., Cash A.D., Honda K., Petersen R.B., Perry G. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. Journal of Alzheimer's Disease 2004, 6:165-169.
11. Castellani R.J., Siedlak S.L., Perry G., Smith M.A. Sequestration of iron by Lewy bodies in Parkinson's disease. Acta Neuropathologica 2000, 100:111-114.
12. Cavadini P., Biasiotto G., Poli M., Levi S., Verardi R., Zanella I., Derosas M., Ingrassia R., Corrado M., Arosio P. RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload. Blood 2007, 109:3552-3559.
13. Cazzola M., Invernizzi R. Ring sideroblasts and sideroblastic anemias. Haematologica 2011, 96:789-792.
14. Cazzola M., Invernizzi R., Bergamaschi G., Levi S., Corsi B., Travaglino E., Rolandi V., Biasiotto G., Drysdale J., Arosio P. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 2003, 101:1996-2000.
15. Combs C.K., Karlo J.C., Kao S.C., Landreth G.E. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. Journal of Neuroscience 2001, 21:1179-1188.
16. Connor J.R., Menzies S.L., St Martin S.M., Mufson E.J. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains. Journal of Neuroscience Research 1990, 27:595-611.
17. Connor J.R., Menzies S.L., St Martin S.M., Mufson E.J. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. Journal of Neuroscience Research 1992, 31:75-83.
18. Corsi B., Cozzi A., Arosio P., Drysdale J., Santambrogio P., Campanella A., Biasiotto G., Albertini A., Levi S. Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. Journal of Biological Chemistry 2002, 277:22430-22437.
19. Crichton R.R., Ward R.J. Metal-based Neurodegeneration: From Molecular Mechanisms to Therapeutic Strategies 2006, vol. 1. John Wiley and Sons, Chichester.
20. Crichton R.R., Dexter D.T., Ward R.J. Brain iron metabolism and its perturbation in neurological diseases. Journal of Neural Transmission 2011, 118:301-314.
21. Deibel M.A., Ehmann W.D., Markesbery W.R. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. Journal of the Neurological Sciences 1996, 143:137-142.
22. Dexter D.T., Wells F.R., Agid F., Agid Y., Lees A.J., Jenner P., Marsden C.D. Increased nigral iron content in postmortem parkinsonian brain. Lancet 1987, 2:1219-1220.
23. Drysdale J., Arosio P., Invernizzi R., Cazzola M., Volz A., Corsi B., Biasiotto G., Levi S. Mitochondrial ferritin: a new player in iron metabolism. Blood Cells, Molecules, and Diseases 2002, 29:376-383.
24. Dwork A.J., Schon E.A., Herbert J. Nonidentical distribution of transferrin and ferric iron in human brain. Neuroscience 1988, 27:333-345.
25. Exley C. Aluminium and iron, but neither copper nor zinc, are key to the precipitation of beta-sheets of Abeta_{42} in senile plaque cores in Alzheimer's disease. Journal of Alzheimer's Disease 2006, 10:173-177.
26. Faucheux B.A., Nillesse N., Damier P., Spik G., Mouatt-Prigent A., Pierce A., Leveugle B., Kubis N., Hauw J.J., Agid Y., Hirsch E.C. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:9603-9607.
27. Fillebeen C., Descamps L., Dehouck M.P., Fenart L., Benaïssa M., Spik G., Cecchelli R., Pierce A. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. Journal of Biological Chemistry 1999, 274:7011-7017.
28. Garrick M.D. Human iron transporters. Genes and Nutrition 2011, 6:45-54.
29. Giometto B., Bozza F., Argentiero V., Gallo P., Pagni S., Piccinno M.G., Tavolato B. Transferrin receptors in rat central nervous system. An immunocytochemical study. Journal of the Neurological Sciences 1990, 98:81-90.
30. Goldstein S., Meyerstein D., Czapski G. The Fenton reagents. Free Radical Biology and Medicine 1993, 15:435-445.
31. Gotz M.E., Double K., Gerlach M., Youdim M.B., Riederer P. The relevance of iron in the pathogenesis of Parkinson's disease. Annals of the New York Academy of Sciences 2004, 1012:193-208.
32. Hahn P., Milam A.H., Dunaief J.L. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Archives of Ophthalmology 2003, 121:1099-1105.
33. Hahn P., Dentchev T., Qian Y., Rouault T., Harris Z.L., Dunaief J.L. Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina. Molecular Vision 2004, 10:598-607.
34. Han J., Day J.R., Connor J.R., Beard J.L. H and L ferritin subunit mRNA expression differs in brains of control and iron-deficient rats. Journal of Nutrition 2002, 132:2769-2774.
35. He X., Hahn P., Iacovelli J., Wong R., King C., Bhisitkul R., Massaro-Giordano M., Dunaief J.L. Iron homeostasis and toxicity in retinal degeneration. Progress in Retinal and Eye Research 2007, 26:649-673.
36. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., Butterfield D.A. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:3270-3274.
37. Honda K., Casadesus G., Petersen R.B., Perry G., Smith M.A. Oxidative stress and redox-active iron in Alzheimer's disease. Annals of the New York Academy of Sciences 2004, 1012:179-182.
38. Honda K., Smith M.A., Zhu X., Baus D., Merrick W.C., Tartakoff A.M., Hattier T., Harris P.L., Siedlak S.L., Fujioka H., Liu Q., Moreira P.I., Miller F.P., Nunomura A., Shimohama S., Perry G. Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. Journal of Biological Chemistry 2005, 280:20978-20986.
39. Huang X., Moir R.D., Tanzi R.E., Bush A.I., Rogers J.T. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Annals of the New York Academy of Sciences 2004, 1012:153-163.
40. Hwang E.M., Kim S.K., Sohn J.H., Lee J.Y., Kim Y., Kim Y.S., Mook-Jung I. Furin is an endogenous regulator of alpha-secretase associated APP processing. Biochemical and Biophysical Research Communications 2006, 349:654-659.
41. Jefferies W.A., Food M.R., Gabathuler R., Rothenberger S., Yamada T., Yasuhara O., McGeer P.L. Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Research 1996, 712:122-126.
42. Jiang D., Li X., Williams R., Patel S., Men L., Wang Y., Zhou F. Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease. Biochemistry 2009, 48:7939-7947.
43. Kawamata T., Tooyama I., Yamada T., Walker D.G., McGeer P.L. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. American Journal of Pathology 1993, 142:1574-1585.
44. Kehrer J.P. The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 2000, 149:43-50.
45. Kell D.B. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Archives of Toxicology 2010, 84:825-889.
46. Lecanu L., Greeson J., Papadopoulos V. Beta-amyloid and oxidative stress jointly induce neuronal death, amyloid deposits, gliosis, and memory impairment in the rat brain. Pharmacology 2006, 76:19-33.
47. Leveugle B., Spik G., Perl D.P., Bouras C., Fillit H.M., Hof P.R. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Research 1994, 650:20-31.
48. Levi S., Arosio P. Mitochondrial ferritin. International Journal of Biochemistry and Cell Biology 2004, 36:1887-1889.
49. Levi S., Corsi B., Bosisio M., Invernizzi R., Volz A., Sanford D., Arosio P., Drysdale J. A human mitochondrial ferritin encoded by an intronless gene. Journal of Biological Chemistry 2001, 276:24437-24440.
50. LeVine S.M. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Research 1997, 760:298-303.
51. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
52. Misonou H., Morishima-Kawashima M., Ihara Y. Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry 2000, 39:6951-6959.
53. Moos T. Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system. Journal of Comparative Neurology 1996, 375:675-692.
54. Moos T., Morgan E.H. Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid. Journal of Neuroscience Research 1998, 54:486-494.
55. Moos T., Morgan E.H. The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain. Journal of Neurochemistry 2004, 88:233-245.
56. Moos T., Oates P.S., Morgan E.H. Expression of the neuronal transferrin receptor is age dependent and susceptible to iron deficiency. Journal of Comparative Neurology 1998, 398:420-430.
57. Moos T., Skjoerringe T., Gosk S., Morgan E.H. Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1. Journal of Neurochemistry 2006, 98:1946-1958.
58. Moos T., Rosengren Nielsen T., Skjorringe T., Morgan E.H. Iron trafficking inside the brain. Journal of Neurochemistry 2007, 103:1730-1740.
59. Napier I., Ponka P., Richardson D.R. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 2005, 105:1867-1874.
60. Nie G., Sheftel A.D., Kim S.F., Ponka P. Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis. Blood 2005, 105:2161-2167.
61. Ohgami R.S., Campagna D.R., McDonald A., Fleming M.D. The Steap proteins are metalloreductases. Blood 2006, 108:1388-1394.
62. Ostrerova-Golts N., Petrucelli L., Hardy J., Lee J.M., Farer M., Wolozin B. The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. Journal of Neuroscience 2000, 20:6048-6054.
63. Pinero D.J., Hu J., Connor J.R. Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains. Cellular and Molecular Biology (Noisy-le-Grand) 2000, 46:761-776.
64. Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993, 11:575-580.
65. Richardson D.R., Lane D.J.R., Becker E.M., Huang M.L.H., Whitnal M., Rahmanto Y.S., Sheftel A.D., Ponka P. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:10775-10782.
66. Rogers J.T., Randall J.D., Cahill C.M., Eder P.S., Huang X., Gunshin H., Leiter L., McPhee J., Sarang S.S., Utsuki T., Greig N.H., Lahiri D.K., Tanzi R.E., Bush A.I., Giordano T., Gullans S.R. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. Journal of Biological Chemistry 2002, 277:45518-45528.
67. Rothenberger S., Food M.R., Gabathuler R., Kennard M.L., Yamada T., Yasuhara O., McGeer P.L., Jefferies W.A. Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium. Brain Research 1996, 712:117-121.
68. Sangchot P., Sharma S., Chetsawang B., Porter J., Govitrapong P., Ebadi M. Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture. Developmental Neuroscience 2002, 24:143-153.
69. Santambrogio P., Biasiotto G., Sanvito F., Olivieri S., Arosio P., Levi S. Mitochondrial ferritin expression in adult mouse tissues. Journal of Histochemistry and Cytochemistry 2007, 55:1129-1137.
70. Schmidauer C., Sojer M., Seppi K., Stockner H., Hogl B., Biedermann B., Brandauer E., Peralta C.M., Wenning G.K., Poewe W. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Annals of Neurology 2005, 58:630-634.
71. Shi Z.H., Nie G., Duan X.L., Rouault T., Wu W.S., Ning B., Zhang N., Chang Y.Z., Zhao B.L. Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease. Antioxidants and Redox Signalling 2010, 13:783-796.
72. Sian-Hulsmann J., Mandel S., Youdim M.B., Riederer P. The relevance of iron in the pathogenesis of Parkinson's disease. Journal of Neurochemistry 2011, 118:939-957.
73. Silvestri L., Camaschella C. A potential pathogenetic role of iron in Alzheimer's disease. Journal of Cellular and Molecular Medicine 2008, 12:1548-1550.
74. Silvestri L., Pagani A., Camaschella C. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 2008, 111:924-931.
75. Smith M.A., Harris P.L., Sayre L.M., Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:9866-9868.
76. Smith M.A., Wehr K., Harris P.L., Siedlak S.L., Connor J.R., Perry G. Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Research 1998, 788:232-236.
77. Snyder A.M., Wang X., Patton S.M., Arosio P., Levi S., Earley C.J., Allen R.P., Connor J.R. Mitochondrial ferritin in the substantia nigra in restless legs syndrome. Journal of Neuropathology and Experimental Neurology 2009, 68:1193-1199.
78. Snyder A.M., Neely E.B., Levi S., Arosio P., Connor J.R. Regional and cellular distribution of mitochondrial ferritin in the mouse brain. Journal of Neuroscience Research 2010, 88:3133-3143.
79. Stenirri S., Santambrogio P., Setaccioli M., Erba B.G., Pia Manitto M., Rovida E., Ferrari M., Levi S., Cremonesi L. Study of FTMT and ABCA4 genes in a patient affected by age-related macular degeneration: identification and analysis of new mutations. Clinical Chemistry and Laboratory Medicine 2012, 50:1021-1029.
80. Tooyama I., Kawamata T., Akiyama H., Moestrup S.K., Gliemann J., McGeer P.L. Immunohistochemical study of alpha 2 macroglobulin receptor in Alzheimer and control postmortem human brain. Molecular and Chemical Neuropathology 1993, 18:153-160.
81. Tooyama I., Kawamata T., Akiyama H., Kimura H., Moestrup S.K., Gliemann J., Matsuo A., McGeer P.L. Subcellular localization of the low density lipoprotein receptor-related protein (alpha 2-macroglobulin receptor) in human brain. Brain Research 1995, 691:235-238.
82. Wang L., Yang H., Zhao S., Sato H., Konishi Y., Beach T.G., Abdelalim E.M., Bisem N.J., Tooyama I. Expression and localization of mitochondrial ferritin mRNA in Alzheimer's disease cerebral cortex. PLoS ONE 2011, 6:e22325.
83. Winterbourn C.C. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicology Letters 1995, 82-83:969-974.
84. Winterbourn C.C., Peskin A.V., Parsons-Mair H.N. Thiol oxidase activity of copper, zinc superoxide dismutase. Journal of Biological Chemistry 2002, 277:1906-1911.
85. Wu W.S., Zhao Y.S., Shi Z.H., Chang S.Y., Nie G.J., Duan X.L., Zhao S.M., Wu Q., Yang Z.L., Zhao B.L., Chang Y.Z. Correction to mitochondrial ferritin attenuates beta-amyloid-induced neurotoxicity: reduction in oxidative damage through the Erk/P38 mitogen-activated protein kinase pathways. Antioxidants and Redox Signalling 2013, 18:158-169.
86. Yamada T., Tsujioka Y., Taguchi J., Takahashi M., Tsuboi Y., Moroo I., Yang J., Jefferies W.A. Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease. Brain Research 1999, 845:1-5.
87. Zanella I., Derosas M., Corrado M., Cocco E., Cavadini P., Biasiotto G., Poli M., Verardi R., Arosio P. The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin. Biochimica et Biophysica Acta 2008, 1782:90-98.
88. Zecca L., Youdim M.B., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nature Reviews Neuroscience 2004, 5:863-873.
89. Zhang Y., Dawson V.L., Dawson T.M. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiology of Disease 2000, 7:240-250.